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Abstract
This chapter is an extensive review of allergen-based diagnostic methodologies 
including old techniques such as skin prick test, radio-allergo sorbent test, enzyme-
linked immunosorbent assay, and fluorescent-enzyme immunosorbent assay. Novel 
technologies include functional tests by flow cytometry and molecular allergy based 
on multiplex immunoassays. We also review the importance of biochemical charac-
teristics of allergens, sensitivity and specificity, cross-reaction between allergens, util-
ity, reproducibility, interpretation, and methodologies for discovery of epitopes for 
diagnostic or therapeutic use.
Keywords: allergens, skin prick test, RAST, ELISA, FEIA, ISAC, FACS, BAT, flow 
cytometry, antigen-antibody reaction, diagnostic
1. Introduction
Allergic diseases have been considered a worldwide health problem. The incidence and 
prevalence of hypersensitivity/allergy conditions are increasing every day, affecting peo-
ple of any age, damaging a broad range of organs, and making a diagnostic challenge 
for the clinician [1]. It is well known that an accurate diagnosis could affect the clinical 
outcome; this is particularly important for the treatment of allergic diseases because the 
identification of the causative antigen and other molecules associated with specific immu-
nological activation by allergen-based tests allows personalized medicine and precision 
treatment [2].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Historical perspective of allergen-based diagnostic methodologies
2.1. Skin prick test (SPT)
Skin prick testing is an essential clinical test to confirm sensitization in IgE-mediated allergic 
diseases. Historically, we can found an early report in 1850, in a textbook of Henry Salter, a 
physician from London´s Charing Cross Hospital who described the formation of wheals 
following scratches in patients with asthma and exposed to cats [3]. In 1907, Clemens von 
Pirquet reported a modification of Koch´s subcutaneous procedure based in abrasion of the 
skin to evaluate tuberculin response [4]. This procedure was rapidly adopted by others as a 
prototype for prick-puncture testing, and in 1909, the first case of anaphylactic response after 
scarification and exposition to an allergen was reported [5]. Practical application of a stan-
dardized procedure was suggested by Schloss [6] who described a correlation of time with 
clinical signs, reporting 5–15 min of erythematous reaction after abrasion of the skin in a child 
with rhinitis, asthma, and eczema. Since then, several techniques to evaluate allergenic sensi-
tization have been described, e.g., intracutaneous test, [7] conjunctival test, [8] intracutaneous 
test by serial dilutions [9]. Nowadays the best technique to evaluate with safety allergenic 
sensitization is the SPT.
The standardized method of prick testing includes the appropriate selection of allergens, i.e., 
allergens tested are according to the country, the geographic location inside the same country, 
and even with seasons [10, 11]. SPT is based on the presence of sensitized cells, mainly mast 
cells in the skin, and the resulted cutaneous reactivity is used by the clinician as a surrogate 
biomarker for sensitization in eyes, nose, lung, gut, and skin. During the test, positive and 
negative controls must be included, a positive result is defined with a wheal ≥3 mm diameter 
after 15–20 min; reproducible results are obtained with standardized mixtures [12, 13]. In the 
early years of use, skin prick testing did not have with the entire approbation of the medical 
community, and their clinical relevance was questioned [14]. That vision has changed, and in 
the last years, it has been recognized a concordance between the clinical manifestations and 
allergen-specific wheal size [15]. Thus, skin prick test is considered as a fundamental tech-
nique to explore allergen sensitization in patients, but if it is true, why we need other methods 
to study sensitization in allergic/hypersensitivity conditions? In the following paragraphs, we 
will explain applications of the most common laboratory assays used to evaluate IgE specific-
ity and the information obtained in functional allergen-based tests.
2.2. IgE and allergy
The discovery of the reaginic activity in the IgE antibody by Ishizaka in 1967 [16] developed a 
revolution in the knowledge of allergy affecting not only in basic research but also in applied 
research resulting in innovative diagnostic tools. It is well known that patients with allergy 
have a tendency to produce high levels of IgE antibodies due to its atopic condition. Usually, 
the concentration of total IgE in serum from healthy individuals ranges below 1 µg/mL. It is 
worthy of note that this is a very low concentration of protein so many laboratories rather use 
IU/mL or kU/L instead of µg/mL to report IgE levels, but understanding that 1 kU/L equals 
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to 2.4 ng/mL [17]. Total IgE does not correlate with clinical manifestations, and is preferably 
to measure specific IgE (sIgE) [18, 19]. Total IgE concentration is the addition of all the spe-
cific IgE (sIgE) to the different allergens the individual has been exposed to; in non-allergic 
subjects, sIgE levels are below the limits of detection (0.35 kU/L) [20]. Thus, to identify the 
triggering antigen of allergic manifestations, one of the most common laboratory test require-
ment is the determination of sIgE concentration in serum. The quantification of sIgE can be 
performed through several methods based on antigen-antibody reaction, e.g., radio allergo 
sorbent test (RAST), enzyme-linked immunosorbent assay (ELISA) and fluorescence enzyme 
immune assay (FEIA).
3. Antigen-antibody reaction for IgE detection: general principle
Quantification of IgE is based on the antigen-antibody reaction, in which antigen is recog-
nized specifically by an antibody forming an immune complex (Figure 1). In these tests, the 
antigen corresponds to serum IgE, and the antibody reacts against IgE in the serum sample. 
To carry out these assays, a specific antibody for the Fc fraction of the IgE is adsorbed into a 
solid phase usually in polystyrene or cellulose wells. This so-called “primary antibody” or 
“capture antibody” has the function of binding to the IgE in the sample of serum; this inter-
action generates a stable bound. Then, this immune complex is measured through a second 
antibody called “secondary antibody” or “detection antibody” which is coupled to a radio-
isotope (RAST) or an enzyme which allows the development of a colored (ELISA) or fluores-
cent (FEIA) substrate in an antigen-dependent manner. Simultaneously, a calibration curve 
containing known concentrations of the analyte to determine is processed to extrapolate the 
data of absorbance (in colorimetric methods—ELISA) or the fluorescence (in fluorometric 
methods—FEIA) to a protein concentration, finally reported in µg, ng, or IU.
Figure 1. Antigen-antibody reaction. Each antibody is able to bind its specific antigen, forming antigen-antibody 
complexes. Different laboratory testing techniques are based on this principle.
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3.1. Radio allergo sorbent test (RAST)
RAST was the first laboratory method developed for in vitro detection of specific IgE [21]; 
despite that it is no longer used and its historical importance is evident since it was the second 
most used test after SPT, and gave rise to development of new methodology to facilitate sIgE 
detection. The main advantage of this method over SPT lied on the safety of patient. In SPT, 
the allergen is administered in the cutaneous layer of the skin, which may lead to sensitiza-
tion to new allergens or in the worst of cases it may trigger anaphylaxis. All of the previous 
disadvantages were avoided with the introduction of in vitro tests like RAST.
As mentioned above, this test is based on the principle of antigen-antibody reaction. In this 
method, the allergen is adsorbed covalently to a solid particle, then, the serum of a patient is 
added. IgE antibodies present in the sample binds to the adsorbed allergen. After this, a wash-
ing step is needed to remove non-specific weak bindings. Next, a radio-iodinated anti-IgE 
antibody is added to this reaction, and finally, the radiation detected is directly proportional 
to the number of antigen-antibody complexes formed (Figure 2).
This method was validated in comparison with sIgE in pollen-sensitized individuals, finding 
96% of concordance with both tests [22].
3.2. Enzyme-linked immunosorbent assay (ELISA)
ELISA is currently one of the most common immune-assays used in clinical and experimen-
tal procedures. This technique allows detection of allergy-related analytes, e.g., IgE or Th2 
cytokines, and screening of different molecules. Advantages of ELISA are fast performance, 
improved biosafety when compared with radioimmunoassay, low reagent cost, affordability 
for the patient, and simple methodology [23].
The first step to perform an ELISA is sensitizing the plate. A solid polystyrene plate is coated 
with an anti-IgE antibody directed against Fc region of the immunoglobulin (capture anti-
body). This process is achieved pre-treating the plate wells with carbonate buffers or cyano-
gen bromide allowing a better chance for adsorbing the capture antibody or antigen. Another 
Figure 2. RAST methodology. An allergen is adsorbed covalently to a solid particle, then serum of patient is added to 
react with the allergen. Next, a radiolabeled anti-IgE antibody identifies the previous formed immune complexes. The 
radiation generated is measured by a radiation detector.
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strategy is to radiate the polystyrene plate; this permits the breaking of a certain number 
of benzene rings yielding carboxyl (COOH) and hydroxyl (OH) groups. Radiation of poly-
styrene increases the chances for hydrophilic interactions with Fc fractions of capture anti-
body. Protein A from Staphylococcus aureus is also a suitable linker for orienting and spacing 
the capture antibody appropriately, optimizing the space, and homogenizing the coating. In 
this step, several factors like pH and temperature could affect the proper adsorption of anti-
body or allergen. Fortunately, commercial kits contain the pre-sensitized plates. Next step is 
incubation of samples (serum or plasma), although serum samples are preferred over plasma 
samples since some commercial houses have documented diminishing IgE detection sensitiv-
ity in plasma samples.
Incubation let the captured antibody bind to IgE through Fc fraction (in total IgE determina-
tion) or allows the specific IgE contained in the sample bind to the allergen adsorbed in the 
solid phase (in specific IgE determination). After incubation time, a washing step is performed 
to remove weak and unspecific binding. Then, a second anti-Fc antibody is added to the well 
to detect the immune complexes formed in the previous step. This “secondary or detection 
antibody” is linked to an oxidative enzyme that acts on its substrate which once oxidized 
develops a color that can be measured trough a spectrophotometer (Figure 3).
There are various enzymes and substrates commonly used in ELISA (Table 1); the biotin-
streptavidin system is the most often employed in detection methods. A washing step is fol-
lowed next to eliminate the excess of not bound antibodies. In addition to samples, control 
or standard curve is processed with increasing concentrations of protein. The goal of this 
standard curve is to extrapolate the absorbance obtained from samples into a curve of known 
concentration through a linear regression, and obtaining an estimated concentration of the 
analyte (Figure 4).
The last step consists in adding and incubating the substrate for 10–20 min and reading the 
absorbance obtained after stopping the reaction. Some substrates may be read without stopping 
Figure 3. ELISA assays. Direct ELISA mostly used for antigen detection. Indirect ELISA mainly used for antibodies 
detection. Sandwich ELISA used to detect total IgE.
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Figure 4. Absorbance-concentration standard curve. In order to determine sIgE concentration in a sample, a standard 
curve is run using known concentrations of total or allergen-specific IgE. By plotting the absorbance from patient 
samples into the standard curve, we can determine sIgE concentration.
the reaction. Results are read in a spectrophotometer; this equipment works emitting a light 
beam that is filtered through a wavelength selector or filter; then, the filtered light will strike the 
sample, which will absorb a certain amount of light and let some light pass and reach the detec-
tor. Absorbance is the negative logarithm of transmittance, so the absorbance obtained will be 
proportional to the concentration of the measured antigen-antibody complexes in the samples 
that may reflect and refract the light at a certain wavelength (Figure 5). Optical density (OD) is 
a common term used to refer to absorbance (see Figures 4 and 5).
ELISA rapidly substituted radiolabeled methods, due to its safer and faster performance, with 
a similar sensibility and specificity when compared to RAST and paper radio immuno-sor-
bent test (PRIST) for total or specific IgE quantification [24, 25]. 
Enzyme Substrate Wavelength after stop solution (nm)
Horse radish peroxidase (HRP) 3,3′,5,5′-tetramethylbenzidine, TMB 450
2,2′-Azinobis 
(3-Ethylenbenzothiazoline-6-sulfonic 
acid) diamonium salt, ABTS
450
o-phenylenediamine dyhidocloride, 
OPD
490
Alkaline phosphatase (AP) p-Nitrophenyl phospate disodium 
salt
450
Table 1. Enzymes and substrates used in ELISA assays.
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3.3. Fluorescent enzyme immune assay (FEIA)
Fluorescent enzyme immune assays are based on the same principle used for ELISA and 
RAST, the antigen-antibody reaction, but differs in the way the read out is made. In FEIA, 
the secondary antibody is linked to an enzyme that permits the activation of a fluorochrome. 
The most common enzyme used in fluorometric assays is β-galactosidase, which acts on its 
substrate 4-methylumbelliferyl-β-D-galactoside transforming it into a 4-methylumbellifer-
one. When 4-methylumbelliferone is excited at 365 nm, it emits fluorescence at 445 nm. This 
fluorescence is later measured by a fluorometer [26]. Simultaneously, a standard curve is pro-
cessed to extrapolate the relative fluorescence units obtained from samples into the known 
concentration curve (Figure 6).
Fluorometric assays have permitted the development of automatized systems, resulting in 
improved reproducibility, diminished operator involvement, with reduction of mistakes, and 
increased sensitivity and specificity when compared with other innovative methods based on 
chemiluminescence [27, 28]. FEIA technology opens the possibility to screen sIgE to several 
allergens at the same time and with few volume of sample [29]. Table 2 shows a comparison 
between antigen-antibody reaction-based methods for quantification of sIgE.
3.4. ImmunoCAP-ISAC (immuno solid-phase allergen chip)
Innovative and non-invasive techniques led to the identification of many sIgE to different 
allergens at the same time, with a minimum sample volume (~50 µL), allowing test allergens 
not limited to a geographical region, and without risk of sensitization, or anaphylaxis for the 
patient, as has been reported for SPT [30].
ISAC is the first multiplex diagnostic tool commercially available to evaluate sIgE directed 
against 112 well-characterized antigens. In fact, the allergens presented in the solid phase are 
recombinant proteins ensuring specific interaction of serum IgE with higher accuracy when 
Figure 5. Spectrophotometer basis. A light beam is generated by a halogen lamp, and this light is filtered through a 
wavelength selector. Light hits the sample and the transmittance measured is reported as absorbance units. Absorbance 
is directly proportional to the amount of antibody-antigen complexes formed previously.
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compared with FEIA and SPT [31]. The assay consists of various steps. First, the sIgE from 
serum samples interacts with the recombinant allergen previously adsorbed to the solid-
phase; then, a secondary anti-human IgE antibody labeled with fluorochrome recognizes 
sIgE-recombinant allergen complex (Figure 7). Fluorescence is measured using a biochip; and 
results are scanned and analyzed in specialized software, reporting results in arbitrary units 
named ISAC Standardized Units (ISU) (Figure 8) [32].
Figure 6. Fluorescence-concentration standard curve. Quantification of sIgE is measured plotting fluorescence units 
obtained from samples into a standard curve.
Test RAST ELISA FEIA
Specificity Depends on antigen 
preparation
High High
Sensitivity High High High
Reproducibility Acceptable Acceptable High
Automatization Partially Partially Totally
Relative cost per test Low Affordable High
Shelf life of reagents Long Low Long
Health hazards for 
laboratory personnel
High Non or minor Non or minor
Table 2. Methods for sIgE quantification based on the antigen-antibody reaction.
Allergen84
ISAC multiplex assay has been proposed to guide therapeutic decisions, e.g., the discontinu-
ation of restrictive diets, the content of allergen-specific desensitization immunotherapy that 
may be useful to discriminate structurally similar allergens and cross-reactivity, and even to 
analyze the real sensitization profile in multi-sensitized patients to define whether they can 
receive a specific immunotherapy [33].
Figure 7. Immuno CAP-ISAC. The recombinant allergens are recognized by sIgE from serum samples; a secondary 
antibody fluorescent-labeled interacts with IgE. Fluorescence is measured by a biochip and results are analyzed in 
specialized software. Recombinant allergen diminishes the risk of cross-reactivity.
Figure 8. ISAC biochip layout. Results are reported in arbitrary units named ISAC-Standardized Units (ISU).
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3.5. Western blot
Western blot combines different techniques to identify new antigens related to allergy. In this 
method, the antigens are separated according to their molecular weight in a sodium dodecyl 
sulfate polyacrylamide gel (SDS-PAGE), and then transferred to a polyvinylidene difluoride 
or nitrocellulose membrane, which will function as the solid phase for the antigen-antibody 
reaction. Then, the membrane is incubated with the patient serum, if sIgE is present in the 
sample it will react against the allergens found. A secondary anti-IgE antibody coupled to an 
enzyme is added (Table 1). Detection of sIgE becomes evident by the formation of bands in 
two different ways:
(a) Developing color. The enzyme oxidizes the substrate and precipitates (e.g., when using a 
secondary antibody conjugated to horse radish peroxidase (HRP) and 4-cloronaphthol).
(b) Releasing light. The substrate is dephosphorylated by an enzyme, releasing light (chemi-
luminescence), that is later detected by a photographic film or autoradiography (i.e., 
when using a secondary antibody conjugated to alkaline phosphatase (AP) and adaman-
tyl-1,2-dioxetane phosphate or HRP and luminol) (Figure 9). Finally, concentration can be 
estimated by densitometer analysis.
Figure 9. Western-blot methodology. Allergen mixtures are separated in a SDS-PAGE according to the molecular size. 
The separated allergens are transferred to a nitrocellulose or PVDF membrane. Then, by adding the antibodies from 
the serum samples sIgE will bind to their specific antigen. An enzyme conjugate secondary antibody identifies Fcɛ IgE. 
Detection of reaginic antibodies is identified by chemiluminescence.
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This method has been useful in the identification of clinically relevant immunogenic epitopes 
after enzymatic digestion of allergens and is also used to identify cross-reacting peptides [34–36].
4. Limitations of sIgE determinations: allergen cross-reactivity
Something to consider when handling sIgE quantification is the cross-reactivity of certain 
allergens. Some allergens share amino acidic sequences that can be recognized by the same 
IgE antibody, and this phenomenon is called “cross-reactivity.” Cross-reactivity occurs mainly 
in aeroallergens and food allergens. It is considered to have a high chance of cross-reactivity 
when two allergens share 35% homology in an 80-amino acid sequence or full identity in a 6–8 
amino acid peptide; also, there may be a cross-reaction when the IgE is specific for carbohy-
drate moiety in the allergen. Hence, laboratory blood tests may detect antibodies to allergens 
even if the patient has never been exposed to them [37].
Importantly cross-reactivity can occur between allergens from the same family like in nut 
allergens or in different species of house dust mite; but also, cross-reactivity could be present 
in diverse phylogenetic sources like house dust mite and shrimp, birch and apple, or fish and 
chicken meat (Table 3) [38–40]. As we read in the previous section, technology innovation 
through recombinant allergens and full automatization notably reduce cross-reactivity risk 
when performing sIgE determinations.
5. Functional tests
The techniques above described answer two simple requests: is the sIgE present in the sample? 
So, if there, how much sIgE is present? The answer to these questions and the analysis of the 
clinical history allows the allergist/immunologist to initiate treatments centered on allergen-
specific desensitization in every single patient in a personalized way. However, sometimes 
Cross-reactivity Antigens involved on cross-reactivity
Birch-apple Bet v1 homologue Mal d1
Cypress-peach Pru p3 non-specific lipid transfer protein (LTP)
Celery-mugwort-spice Art v4 profilin, Art v60 kDa homologue to Api g5
Mugwort-peach Art v4 profilin, Art v3 LTP
Alternaria-spinach Alt a1
Mite-shrimp Der p10, tropomyosin
Cat-pork Fel d2 cat serum albumin
Bird-egg Gal d5 alpha-livetin (chicken serum albumin)
Table 3. Allergen cross-reactivity and antigens involved.
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answer to these questions is not enough, and functional tests are needed to understand some 
clinical manifestations, e.g. allergy to a particular drug.
5.1. Flow cytometry and fluorescence-activated cell sorting (FACS)
Early in the 1950s, Coulter developed a technology able to read size and complexity of 
blood cells based on diffraction of light laying the fundamentals for automatized blood 
counting used in our days. Exploiting this innovation, Bonner, Sweet, Hulett, Herzenberg 
invented the Fluorescence Activated Cell Sorter (FACS) in the late 1960s to achieve flow 
cytometry and cell sorting of viable cells. Becton Dickinson with Bernie Shoor introduced 
the commercial cytometers in the early 1970s, utilizing a Stanford patent and the expertise 
supplied by the Herzenberg Laboratory [41]. Today, isolation of cells by FACS is performed 
in complete sterility, and sorted cells could be used as an adoptive transfer for therapeutical 
interventions [42].
Flow cytometry detects and analyzes optical signals (angular light scatter or emitted fluores-
cence) to identify individual characteristics of cells or in biological samples. Inside the flow 
cytometer, the suspended cells are conducted in a fluidic system ensuring cells travel at a uni-
form velocity in a laminar form. Here, the cells are directed to a specific point in which a laser 
passes through cells. The light is diffracted in all directions, the emitted light is recovered in 
filters, and photodetectors collect the detection signals. The optical detection system obtains 
information about forward light scatter (FSC), side light scatter (SSC), and fluorescence chan-
nels (FL1, FL2, FL3). Then, the luminous signal is detected in photomultiplier tubes; infor-
mation recollected is digitalized that is to be analyzed by a computer system. Information 
obtained is showed in histograms or dot plots. The quality of both systems (optical and flu-
idic) is critical for performance and reliability of this technique [43] (Figure 10).
Flow cytometry could be used to determine the expression of cell surface markers, to know 
absolute or relative numbers of cells, to determine intracellular proteins, to quantify soluble 
proteins, or combine all of these possibilities.
(a) Expression of cell surface markers. Information obtained by analysis of expression of cell 
surface markers could be useful to know the cellular phenotype and some functions of 
labeled cells. A few examples include the state of activation of a particular cell [e.g., CD63 
on basophils after drug exposition (see the next section of this chapter for a deeper expla-
nation of basophils activation test)], to know absolute numbers of circulating cells (e.g., 
1700 CD4/µL), or combining information (e.g., patients with ocular allergy have increas-
ing percentage of circulating helper activated CD4+CD25+ T cells) [44].
(b) Determination of intracellular proteins. This procedure is useful to assess specific func-
tions of the cell. First, isolation of cells is needed prior incubation with a stimulus (e.g., 
allergens as specific stimulus). Culture or incubation conditions must be standardized to 
ensure reproducibility of results. It is important to note that if studied protein is secreted 
(e.g., cytokines) protein secretion must be inhibited (e.g., brefeldin-A that blocks internal 
protein transport) to allow retention of proteins inside the cytoplasm. Labeling of intracel-
lular proteins is performed after cells were fixed and permeabilized with detergents (e.g., 
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saponin). Permeabilization process ensures that monoclonal antibodies (mAbs) labeled 
with fluorochromes enter into the cell and react with their specific antigens (Figure 11) 
[45]. The determination of intracellular proteins has significantly contributed to the un-
derstanding of physiopathology induced by allergens (e.g., Allergen-activation induces 
cytokines related to the damage of IL-25 in asthma, IL-31 in atopic dermatitis, and IL-5 in 
vernal conjunctivitis) [46–48].
(c) Quantification of soluble proteins. The determination of soluble proteins could be used 
to know normal ranges of proteins in human fluids or to assess cellular functions. Multi-
plex technology has been developed to detect several proteins in the same sample, and it 
is named cytometric bead arrays (CBA). The advantage of this test is the low volume of 
sample letting to process a broad range of human fluids/secretions (e.g., tears, synovial 
fluid, aqueous humor, and serum) and cell supernatants [49–52].
Multiple determinations of soluble proteins by flow cytometry are based in microspheres, all 
of them conjugated with a specific antibody against protein we wish to determine. After bead 
interacts with its antigen, a second antibody labeled with a fluorochrome is added; usually, this 
secondary antibody is conjugated to phycoerythrine (PE). However, the real innovation of this 
assay is that each bead is also labeled with a different fluorochrome in a range of intensity, from 
low intensity to high intensity, and detected by near infrared (NIR) lasers [53, 54] (Figure 12).
Figure 10. Flow cytometer and fluorescent activated cell sorter. The figure resumes the optical and the fluidic systems 
working together to analyze biophysical characteristics of cells, expression of molecules detected by monoclonal 
antibodies, and sorting of cells expressing selected characteristics.
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Changes in intensity of fluorescence are expressed as median fluorescence intensity (MFI) and 
directly correlate with concentration of protein in the sample expressed in pg/mL or ng/mL 
(Figure 13).
5.1.1. Basophils activation test (BAT)
Adverse drug reactions (ADR) constitute a major health problem worldwide with high mor-
bidity and mortality rates, the incidence of fatal ADR occurs in 5% in hospitalized patients in 
Europe [55]. ADR may be classified as Type A (augmentation of normal drug effects), Type B 
Figure 11. Determination of intracellular proteins by flow cytometry. Identification of intracellular proteins allows 
studying cellular functions.
Figure 12. Cytometric bead arrays. Multiplex technology permits determination of various soluble proteins at the same 
time, and in the same sample.
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(bizarre effects), Type C (chronic effects), Type D (delayed effects), and Type E (end of drug use 
effects). The most frequent ADR are Type A and are related to genetics, age, sex, and disease, and 
they have low mortality and high morbidity; in contrast, Type B are 25% of ADR and are unpre-
dictable, with high mortality and low morbidity. The pathophysiological mechanisms of Type 
B reactions are not well understood. Some cases are mediated by type I hypersensitivity (true 
allergy), but other cases are related with the generation of reactive metabolites that react non-
enzymatically on multiple proteins to form immunogenic-drugs complexes that induce a cascade 
of cell-based reactions and result in a wide range of severe clinical symptoms [56]. Due to the 
complexity of ADR, only Type B reactions could be explored by basophil activation test (BAT).
Principle of this test is simple, basophils are activated in vitro by the suspicious drug; if 
basophils are sensitized to the drug, they become active, upregulating on their surface two 
molecules CD63 and CD203c [57]. CD63 is an intracellular lysosomal protein whose surface 
expression is upregulated after activation. CD63 is also expressed on activated platelets, 
degranulated neutrophils, monocytes, macrophages, and endothelium [58]. On the other 
hand, CD203c is an ectoenzyme located both on the plasma membrane and in the cytoplasmic 
compartment of basophils. Cross-linking of the FcεRI by an allergen or anti-IgE antibody 
results in a rapid upregulation of intracellular CD203c molecules to the cell surface and is 
accompanied by mediator release [59] (Figure 14).
Figure 13. Standard-curve and median fluorescence intensity (MFI). Changes in MFI correlate with concentration of 
soluble protein.
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Reports about sensitivity and specificity for BAT indicate that determination of both, CD63 
and CD203c, considerably increases the sensitivity up to 92% and specificity in a range of 
86–90% [60, 61]. Today, BAT is also used to determine sensitization to several allergens such 
as diverse types of pollen and house dust mites. It has been reported that BAT has the same 
sensitivity but lower specificity when compared with FEIA. BAT could be used as an alterna-
tive to SPT in some patients with allergy to aeroallergens [62] and as a useful test preventing 
preoperative anaphylaxis [63].
BAT assay is performed with 100 µL of peripheral blood; the drug is incubated with the 
blood at 1 mg/mL, in 36.5°C of temperature and atmosphere of 5% CO
2
 during 1 h; as an 
internal control, the same volume of blood is incubated with negative or positive controls. 
N-formyl-methionyl-leucyl-phenylalanine (f-MLP) is used as positive control. f-MLP is an 
N-formylated tripeptide that functions as a chemotactic peptide for polymorphonuclear 
(PMN) cells but is a potent activator of basophils too. After incubation, cells are labeled with 
monoclonal antibodies for 30 min, and then erythrocytes are lysed and results are analyzed 
by flow cytometry. To ensure that CD63 expressing cells are basophils, analyzed cells are also 
labeled against CD123 and Human leukocyte antigen-DR (HLA-DR). CD123 is the IL-3Rα, 
granulocytes including basophils, that constitutively express this cluster of differentiation 
[64]; whereas HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T 
lymphocytes, activated natural killer (NK) lymphocytes but is absent in basophils. First, we 
analyzed cells by their complexity (SSC) and expression of CD123 and HLA-DR, basophils 
would be CD123+HLA-DR−, and only if activated by allergen or drug-medication, basophils 
would be CD63+ CD203c+ (SSC/CD123+HLA-DR−CD63+CD203c+) (Figure 15).
Figure 14. Basophils activation test. (a) After activation basophils upregulate CD63 and CD203c on membrane surface. 
Both CD63 and CD203c are detected by antibodies conjugated to fluorochromes; (b) the histogram shows increased 
expression of CD203c on gated basophils.
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6. Conclusions
The analytical and functional methods described in this chapter are evolved significantly 
since the first clinical report related to the identification of a triggering allergen in an asth-
matic patient. All the allergen-based diagnostic methodologies revised in this chapter are 
grounded in the antigen-antibody reaction; recognizing the advantages and disadvantages of 
each analytic method is essential to make adequate choices. Although the apparent simplicity 
of methods is described here, some technical considerations have to be considered to avoid 
human errors when performing and interpreting sIgE tests.
It is important to note that the understanding of these techniques could be easy, but to apply 
them to make therapeutical decisions is not as easy. Allergic diseases are the best example of 
precision medicine. In this context, the therapeutical interventions through allergen-specific 
desensitization and addition of biologicals to block the function of certain molecules must be 
argued not only with evidence-based medicine but also with a personalized analysis of every 
single patient. Today technology is under service of science, and we have to be aware of that. 
Figure 15. Representative dot plot of flow cytometry analysis of a basophils activated test. Upper panel shows non-
stimulated cells. The lower panel shows stimulated cells with f-MLP. Percentage of activated basophils is showed at the 
squares next to dot plots.
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The concept of“molecular allergy” is not only to request the laboratory technician for determi-
nations of sIgE by sophisticated methods, but also to understand these techniques and apply 
all this knowledge to benefit our patients. The usage of allergen-based diagnostic methodolo-
gies must reach the patient and not only remain for investigation.
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